Why technology standards are critical for Quantum-Safe Security

Safeguard Insights

May 10, 2010

Q1’10 Quarterly Results Slides Available

Anyone who was unable to participate in Safeguard Scientifics’ first quarter conference call last week can view the entire presentation here. In conjunction with the…

Posted by John E. Shave III

May 7, 2010

Podcast: Safeguard Scientifics’ Quarterly Results Call Podcast Now Available

Anyone who was unable to participate in our first quarter conference call yesterday can download the complete audio file (MP3) here. If you’ve been following…

Posted by John E. Shave III

May 6, 2010

Safeguard Scientifics’ Aggregate Partner Company Revenue Up 46 Percent

This morning, we announced that aggregate partner company revenue for the first quarter 2010 was up 46 percent from $58.4 million for the same partner…

Posted by John E. Shave III

May 5, 2010

Reminder: Safeguard Scientifics’ Quarterly Results Call Tomorrow Morning

REMINDER: First quarter results to be issued tomorrow. Here’s the link.

Posted by John E. Shave III

May 3, 2010

Safeguard Scientifics to Announce First Quarter 2010 Financial Results This Thursday

Thought I’d mention that Safeguard Scientifics is releasing its financial results for the first quarter ended March 31, 2010 prior to market open on Thursday,…

Posted by John E. Shave III

April 28, 2010

Google Goes “Wire”less

“Good afternoon everyone, and welcome to today’s first quarter 2010 earnings conference call. As you know, we are now distributing our earnings release exclusively through…

Posted by John E. Shave III

April 15, 2010

Avid Radiopharmaceuticals Announces Positive Interim Results from Phase III Clinical Trial of Amyloid Imaging Agent Florbetapir F18

Our partner company, Avid Radiopharmaceuticals, announced positive interim results from the Phase III clinical trial of its amyloid imaging agent Florbetapir F18 for early diagnosis…

Posted by Peter J. Boni

March 31, 2010

Avid Radiopharmaceuticals Making Strides Toward Clinical Trial Milestone

I frequently attribute Safeguard Scientifics’ success to our disciplined strategy built on five strategic themes, which we refer to as M2C3. We leverage these themes…

Posted by Peter J. Boni

March 30, 2010

Safeguard Scientifics’ Aggregate Partner Company Revenue and Employment Up; Economy Down

Since coming to Safeguard Scientifics nearly five years ago, our management team created a game plan to transition our partner companies from a group of…

Posted by Peter J. Boni

Content